Free Trial
NASDAQ:AAPG

Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Ascentage Pharma Group International logo
$24.71 -0.64 (-2.52%)
As of 01:16 PM Eastern

About Ascentage Pharma Group International Stock (NASDAQ:AAPG)

Key Stats

Today's Range
$23.06
$25.71
50-Day Range
$17.70
$26.48
52-Week Range
$16.50
$26.55
Volume
16,181 shs
Average Volume
59,946 shs
Market Capitalization
$2.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Receive AAPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter.

AAPG Stock News Headlines

Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
Ascentage Pharma Group International ADR
See More Headlines

AAPG Stock Analysis - Frequently Asked Questions

Ascentage Pharma Group International's stock was trading at $18.67 at the start of the year. Since then, AAPG stock has increased by 32.8% and is now trading at $24.80.
View the best growth stocks for 2025 here
.

Ascentage Pharma Group International (AAPG) raised $126 million in an initial public offering (IPO) on Friday, January 24th 2025. The company issued 7,325,000 shares at a price of $17.25 per share.

Ascentage Pharma Group International's lock-up period expires on Wednesday, July 23rd. Ascentage Pharma Group International had issued 7,325,000 shares in its initial public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. After the end of Ascentage Pharma Group International's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Ascentage Pharma Group International's top institutional investors include Monashee Investment Management LLC (0.18%).

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AAPG
Previous Symbol
NASDAQ:AAPG
Web
N/A
Fax
N/A
Employees
600
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$980.65 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.21 billion
Optionable
N/A
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:AAPG) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners